EQIX vs NYC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Equinix exhibits a severe valuation disconnect, with a current price of $1076.40 dwarfing both its Graham Number ($211.38) and Intrinsic Value ($96.46). The Piotroski F-Score of 4/9 indicates only stable financial health, while a dividend payout ratio of 136.34% is fundamentally unsustainable. Despite strong market positioning in AI infrastructure, the PEG ratio of 5.00 and bearish insider activity from the CEO and CFO suggest the stock is priced for perfection in a way that current growth rates (8.1% YoY) cannot support.
The company exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the stock trades at a deep discount to book value (P/B 0.30), this is likely a value trap given the catastrophic revenue decline of -56.50% YoY and deeply negative operating margins. High leverage (Debt/Equity 3.86) combined with a bearish technical trend (0/100) suggests significant downside risk and potential insolvency concerns.
Compare Another Pair
Related Comparisons
EQIX vs NYC: Head-to-Head Comparison
This page compares Equinix, Inc. (EQIX) and American Strategic Investment Co. (NYC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.